M06.261 Rheumatoid bursitis, right knee

Name of the Condition

• Rheumatoid bursitis, right knee

Summary

Rheumatoid bursitis of the right knee is inflammation of the bursae (fluid-filled sacs that cushion joints) in the right knee, driven by rheumatoid arthritis (RA). This condition results from the immune system’s chronic inflammatory processes affecting the knee’s protective structures, leading to pain, swelling, and restricted mobility. Diagnosis requires correlation of clinical findings with RA history or serologic evidence.

Causes

Rheumatoid bursitis in the right knee arises from the systemic inflammation of rheumatoid arthritis. The immune system’s attack on joint tissues extends to the knee’s bursae, causing fluid accumulation and irritation. While RA is the primary driver, mechanical stress or trauma to the knee may exacerbate inflammation in susceptible individuals.

Risk Factors

• Preexisting rheumatoid arthritis, increasing bursal inflammation risk.
• Advanced age, as RA severity often progresses over time.
• Prolonged knee overuse or pressure, which may irritate bursae.
• Systemic inflammation, as seen in active RA flares.

Symptoms

• Localized swelling and tenderness over the right knee bursae.
• Pain with knee movement or pressure on the inflamed area.
• Reduced range of motion in the right knee joint.
• Warmth or redness (if inflammation is acute).

Diagnosis

Diagnosis of rheumatoid bursitis of the right knee involves clinical evaluation of symptoms, physical examination of the right knee, and correlation with a history of rheumatoid arthritis. Imaging (e.g., ultrasound or MRI) may confirm bursal inflammation, while laboratory tests (e.g., rheumatoid factor, anti-CCP antibodies) support the underlying RA diagnosis. Aspiration of bursal fluid may rule out infection or crystal-induced arthritis.

Treatment Options

Treatment focuses on reducing inflammation and managing RA. Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroid injections into the affected bursa may alleviate pain and swelling. Disease-modifying antirheumatic drugs (DMARDs) or biologics target systemic RA inflammation. Physical therapy and activity modification help preserve knee function. Surgical intervention is rare but may be considered for persistent or infected bursitis.

Prognosis and Follow-Up

Prognosis depends on RA control and adherence to treatment. With proper management, symptoms often improve, but chronic inflammation may lead to recurrent episodes. Regular follow-up with a rheumatologist or orthopedist is essential to monitor RA activity, adjust therapies, and prevent joint damage. Long-term outcomes vary based on disease severity and response to treatment.

Complications

Untreated or poorly controlled rheumatoid bursitis may lead to chronic pain, reduced mobility, or bursal infection. Persistent inflammation can contribute to knee joint damage over time, worsening RA-related disability. Rarely, bursal fluid accumulation may cause mechanical issues or compress nearby structures.

Lifestyle & Prevention

Lifestyle modifications include avoiding repetitive knee stress, using supportive footwear, and maintaining a healthy weight to reduce joint load. Regular low-impact exercise (e.g., swimming) preserves mobility without exacerbating inflammation. RA management (e.g., medication adherence, stress reduction) helps prevent flares that may worsen bursitis. Protecting the knee from trauma minimizes exacerbation risk.

When to Seek Professional Help

Seek medical care if right knee pain, swelling, or stiffness persists despite rest or over-the-counter treatments. Immediate attention is needed for sudden severe pain, fever, or signs of infection (e.g., redness, warmth). Prompt evaluation is critical if RA symptoms worsen or new joint involvement occurs, as early intervention improves outcomes.

Tips for Medical Coders

Document the specific site (right knee) and confirm the underlying rheumatoid arthritis diagnosis for accurate coding. Ensure clinical notes specify the affected bursa (e.g., prepatellar, infrapatellar) and correlate with RA history or serologic evidence. Avoid coding if bursitis is non-rheumatoid or the site is unspecified. Verify documentation supports the M06.261 code’s specificity for right knee involvement.